Ex-vivo expanded allogeneic γδ T cells
Sponsors
Xijing Hospital, Institute of Hematology & Blood Diseases Hospital, China
Conditions
AMLAML (Acute Myelogenous Leukemia)Melanoma
Early Phase 1
Allogeneic Gammadelta T Cells Combined With Interferon-α1b or PD-1 Monoclonal Antibody in Stage III-IV Amenable to Surgical Resection Melanoma
Not yet recruitingNCT06212388
Start: 2024-01-24End: 2028-10-30Target: 10Updated: 2024-01-25
The Efficacy and Safety Assessment of Allogeneic γδ T Cells in Patients With MRD-positive AML After Allo-HSCT
RecruitingNCT07126782
Start: 2025-07-20End: 2028-07-20Target: 10Updated: 2025-08-17